Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | KCNK3 | O14649 | 3/20 | 0.61 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.60 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 1/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12700378 | 0.90 | ALDH1A1 (0.70) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL11864904 | 0.90 | ALDH1A1 (0.67) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL13927138 | 0.90 | ALDH1A1 (0.81) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL18132551 | 0.89 | ALDH1A1 (0.65) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL29204765 | 0.89 | HPSE (0.63) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL9161426 | 0.88 | MEN1 (0.66) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL9164792 | 0.88 | MEN1 (0.66) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL17538449 | 0.86 | KMT2A (0.65) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL6852858 | 0.86 | MEN1 (0.60) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL17538597 | 0.86 | KMT2A (0.65) | ALDH1A1MEN1KMT2AHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2115111-B1 | BENZOPHENONE OR BENZOIC ACID ANILIDE DERIVATIVES CONTAINING CARBOXYL GROUPS AS ENZYME STABILIZERS | HENKEL AG & CO KGAA (DE) | 2014-04-30 | — | — | EP | claimed |
| US-7968508-B2 | Benzophenone or benzoic acid anilide derivatives containing carboxyl groups as enzyme stabilizers | HENKEL AG & CO. KGAA (DE) | 2011-06-28 | — | — | US | claimed |
| US-20100062964-A1 | Benzophenone or Benzoic Acid Anilide Derivatives containing Carboxyl Groups as Enzyme Stabilizers | HENKEL AG & CO., KGAA (DE) | 2010-03-11 | — | — | US | claimed |
| US-12310944-B2 | Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2025-05-27 | — | — | US | disclosed |
| US-20230165833-A1 | Selective Butyrylcholinesterase Inhibitor or Pharmaceutically Acceptable Salt Thereof, Preparation Method and Use Thereof | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2023-06-01 | — | — | US | disclosed |
| WO-2021042410-A1 | SELECTIVE BUTYRYLCHOLINESTERASE INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国药科大学 | 2021-03-11 | — | — | WO | disclosed |
| CN-110627767-B | Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and application thereof | 中国药科大学 | 2020-08-25 | — | — | CN | disclosed |
| CN-110627767-A | Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and application thereof | 中国药科大学 | 2019-12-31 | — | — | CN | disclosed |
| US-10166237-B2 | Compounds and methods for inducing chondrogenesis | THE SCRIPPS RESEARCH INSTITUTE (US) | 2019-01-01 | — | — | US | disclosed |
| US-20170112843-A1 | COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS | THE SCRIPPS RESEARCH INSTITUTE | 2017-04-27 | — | — | US | disclosed |
| US-9464065-B2 | Compounds and methods for inducing chondrogenesis | THE SCRIPPS RESEARCH INSTITUTE (US) | 2016-10-11 | — | — | US | disclosed |
| US-7968508-B2 | Benzophenone or benzoic acid anilide derivatives containing carboxyl groups as enzyme stabilizers | HENKEL AG & CO. KGAA (DE) | 2011-06-28 | — | — | US | disclosed |
| US-7968508-B2 | Benzophenone or benzoic acid anilide derivatives containing carboxyl groups as enzyme stabilizers | HENKEL AG & CO. KGAA (DE) | 2011-06-28 | — | — | US | disclosed |
| WO-2011026107-A1 | PHTHALANILATE COMPOUNDS AND METHODS OF USE | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2011-03-03 | — | — | WO | disclosed |
| US-20100062964-A1 | Benzophenone or Benzoic Acid Anilide Derivatives containing Carboxyl Groups as Enzyme Stabilizers | HENKEL AG & CO., KGAA (DE) | 2010-03-11 | — | — | US | disclosed |
| US-20100062964-A1 | Benzophenone or Benzoic Acid Anilide Derivatives containing Carboxyl Groups as Enzyme Stabilizers | HENKEL AG & CO., KGAA (DE) | 2010-03-11 | — | — | US | disclosed |
| US-20100062964-A1 | Benzophenone or Benzoic Acid Anilide Derivatives containing Carboxyl Groups as Enzyme Stabilizers | HENKEL AG & CO., KGAA (DE) | 2010-03-11 | — | — | US | disclosed |
| EP-2115111-A1 | BENZOPHENONE OR BENZOIC ACID ANILIDE DERIVATIVES CONTAINING CARBOXYL GROUPS AS ENZYME STABILIZERS | Henkel AG & Co. KGaA (DE) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008107030-A1 | BENZOPHENONE OR BENZOIC ACID ANILIDE DERIVATIVES CONTAINING CARBOXYL GROUPS AS ENZYME STABILIZERS | HENKEL AG & CO. KGAA (DE) | 2008-09-12 | — | — | WO | disclosed |
| US-3935015-A | Silver halide color photographic materials containing 3-anilino-5-pyrazolane couplers | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10166237-B2 | Compounds and methods for inducing chondrogenesis | COL2A1, BMP4, BMP2 | ALDH1A1 63/4885MEN1 4660/4885KMT2A 3000/4885 |
| US-20230165833-A1 | Selective Butyrylcholinesterase Inhibitor or Pharmaceutically Acceptable Salt Thereof, Preparation Method and Use Thereof | BCHE, ACHE, BACE1 | ALDH1A1 378/4885MEN1 2484/4885KMT2A 2073/4885 |
| US-20170112843-A1 | COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS | COL2A1, BMP4, BMP2 | ALDH1A1 63/4885MEN1 4660/4885KMT2A 3000/4885 |
| US-12310944-B2 | Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof | BCHE, ACHE, BACE1 | ALDH1A1 399/4885MEN1 2495/4885KMT2A 2226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.